Pressure Biosciences Inc.

OTC: PBIO    
Share price (4/26/24): $0.23    
Market cap (4/26/24): $7.824 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 48 pages Definitions
12/34/56
EX-10.2
from 10-K 7 pages Pressure Biosciences, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.1
from 8-K 3 pages Fourth Amendment to Binding Acquisition Letter of Intent
12/34/56
EX-10.1
from 8-K 2 pages Third Amendment to Binding Acquisition Letter of Intent
12/34/56
EX-10.1
from 8-K 2 pages Second Amendment to Binding Acquisition Letter of Intent
12/34/56
EX-10.4
from 10-Q 4 pages U.S. Small Business Administration Security Agreement
12/34/56
EX-10.2
from 10-Q 2 pages First Amendment to Binding Acquisition Letter of Intent
12/34/56
EX-10.1
from 10-Q 5 pages Pressure Biosciences, Inc. and Cannaworx Binding Acquisition Letter of Intent
12/34/56
EX-10.3
from 10-Q 2 pages Amendment to Standstill and Forbearance Agreement
12/34/56
EX-10.2
from 10-Q 6 pages Standstill and Forbearance Agreement
12/34/56
EX-10.5
from 8-K 28 pages Registration Rights Agreement
12/34/56
EX-10.4
from 8-K 9 pages General Security Agreement
12/34/56
EX-10.3
from 8-K 15 pages Common Stock Purchase Warrant Pressure Biosciences, Inc
12/34/56
EX-10.2
from 8-K 24 pages Pressure Biosciences, Inc. 10% Senior Secured Convertible Promissory Note Due December 20, 2020
12/34/56
EX-10.1
from 8-K 22 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 4 pages Via Electronic Mail Re: Agreement to Convert Debentures; Agreement to Amend Debenture Warrants; Agreement to Receive New Warrants Dear Investor
12/34/56
EX-10.1
from 8-K 4 pages Via Electronic Mail Re: Agreement to Convert – May 2017 Promissory Note Obligation You Are Being Sent This Letter as You Are Currently the Holder of the May 2017 Promissory Note Pursuant to Which You Are Owed Principal Along With Accrued Interest and Origination Fee (The “May 2017 Promissory Note Obligation”). What We Need From You by Executing and Delivering This Letter, You Hereby Agree
12/34/56
EX-10.1
from 10-Q 4 pages Pressure Biosciences, Inc. Amendment Number 3 to October 26, 2016 Promissory Note
12/34/56
EX-10.22
from 10-K 4 pages Pressure Biosciences, Inc. Amendment Number 2 to October 26, 2016 Promissory Note
12/34/56
EX-10.1
from 8-K 21 pages Asset Purchase Agreement
12/34/56